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Abstract 
Background: In malaria-endemic settings, a small proportion of children suffer repeated malaria infections, contrib-
uting to most of the malaria cases, yet underlying factors are not fully understood. This study was aimed to determine 
whether undernutrition predicts this over-dispersion of malaria infections in children aged 6–18 months in settings of 
high malaria and undernutrition prevalence.
Methods: Prospective cohort study, conducted in Mangochi, Malawi. Six-months-old infants were enrolled and had 
length-for-age z-scores (LAZ), weight-for-age z-scores (WAZ), and weight-for-length z-scores (WLZ) assessed. Data 
were collected for ‘presumed’, clinical, and rapid diagnostic test (RDT)-confirmed malaria until 18 months. Malaria 
microscopy was done at 6 and 18 months. Negative binomial regression was used for malaria incidence and modified 
Poisson regression for malaria prevalence.
Results: Of the 2723 children enrolled, 2561 (94%) had anthropometry and malaria data. The mean (standard devia-
tion [SD]) of LAZ, WAZ, and WLZ at 6 months were − 1.4 (1.1), − 0.7 (1.2), and 0.3 (1.1), respectively. The mean (SD)
incidences of ‘presumed’, clinical, and RDT-confirmed malaria from 6 to 18 months were: 1.1 (1.6), 0.4 (0.8), and 1.3 
(2.0) episodes/year, respectively. Prevalence of malaria parasitaemia was 4.8% at 6 months and 9.6% at 18 months. 
Higher WLZ at 6 months was associated with lower prevalence of malaria parasitaemia at 18 months (prevalence ratio 
[PR] = 0.80, 95% confidence interval [CI] 0.67 to 0.94, p = 0.007), but not with incidences of ‘presumed’ malaria (inci-
dence rate ratio [IRR] = 0.97, 95% CI 0.92 to 1.02, p = 0.190), clinical malaria (IRR = 1.03, 95% CI 0.94 to 1.12, p = 0.571), 
RDT-confirmed malaria (IRR = 1.00, 95% CI 0.94 to 1.06, p = 0.950). LAZ and WAZ at 6 months were not associated 
with malaria outcomes. Household assets, maternal education, and food insecurity were significantly associated with 
malaria. There were significant variations in hospital-diagnosed malaria by study site.
Conclusion: In children aged 6–18 months living in malaria-endemic settings, LAZ, WAZ, and WLZ do not predict 
malaria incidence. However, WLZ may be associated with prevalence of malaria. Socio-economic and micro-geo-
graphic factors may explain the variations in malaria, but these require further study.
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Background
Malaria is one of the most serious public health problems 
in the world, with an estimated 216 million cases and 
445,000 deaths reported in 2016, and approximately 90% 
of the cases and deaths occurring in the African Region 
[1]. Malawi is one of the malaria-hyperendemic countries 
in sub-Saharan Africa, with around 4 million malaria cases 
reported annually [2]. In malaria-hyperendemic countries, 
it is assumed that virtually all exposed individuals would 
suffer a malaria episode by early childhood [3]. However, 
several studies have shown that in these settings, only 
a small proportion of children suffer repeated malaria 
infections, and these children are responsible for most of 
the malaria cases [4–6], an over-dispersion known as the 
‘20/80’ rule [7].
The suggested underlying factors for this over-dis-
persion in malaria infections are varied, and include for 
instance genetic [5], behavioural [8] and environmen-
tal factors [6]. Other studies suggest that undernutri-
tion plays an important role in malaria epidemiology 
because of the synergistic interactions between nutri-
tion and infections [9–11]. However, several reviews on 
the relationship between undernutrition and malaria 
determined that the current evidence is inconclusive; 
attributed to the heterogeneity in the study populations, 
malaria parasite species, and host-parasite relationship 
[12–14]. Hence the need for further understanding of 
the role of undernutrition in malaria epidemiology.
The International Lipid-based Nutrient Supplements 
(iLiNS) Project DOSE and DYAD studies were rand-
omized controlled trials conducted in Malawi to study 
the impact of lipid-based nutrient supplements (LNS) 
on growth of children [15, 16]. Analysis of longitudi-
nal malaria data in the two studies showed that 39% 
of the infants and young children aged 6 to 18 months 
did not report any malaria episode in the one-year 
study period; only 30.7% reported more than one epi-
sode of ‘presumed’ malaria but these were responsible 
for 73.7% of the ‘presumed’ malaria episodes [17]. The 
aim of the current analysis was to further investigate 
the distribution of malaria in children in these cohorts 
and determine whether this distribution is predicted by 
anthropometric status at 6 months. The hypothesis was 
that lower length for age z-scores (LAZ), weight-for-age 
z-scores (WAZ), and lower weight for length z-scores
(WLZ) at 6  months will be associated with a higher
incidence of malaria from 6 to 18  months, and higher
prevalence of malaria at 18 months.
Methods
Study setting
The iLiNS-DOSE and iLiNS-DYAD-M studies were 
conducted in four facilities: one public district hospital 
(Mangochi), one mission hospital (Malindi), and two 
rural public health centres (Lungwena and Namwera) in 
Mangochi District, Southern Malawi. The total catch-
ment population of 180,000 largely subsisted on farm-
ing and fishing. Mangochi site is low-lying at an altitude 
of ~ 485  m above sea level, but traversed by the Shire 
River (the largest river in Malawi). Two of the study sites 
(Lungwena and Malindi) are also low-lying with the 
similar altitude along the eastern shore of Lake Malawi. 
In contrast, Namwera lies at the top of Namwera Hills, 
bordering Mozambique, at an altitude of ~ 900  m above 
sea level and is far from the large water bodies. Namwera 
experienced higher rainfall and cooler temperatures than 
the other three study sites [18, 19].
In Malawian children aged < 5 years, the prevalence of 
malaria (by microscopy), diarrhoea and acute respiratory 
infections were 24.3%, 22% and 5%, respectively, with 
seasonal fluctuations [2, 20]. The sub-tropical climate 
comprising a warm, wet season from November to April, 
a cool, dry winter season from May to August, and a hot, 
dry season from September to October [21] is favour-
able for the Anopheles mosquitoes which transmit Plas-
modium parasites. Plasmodium falciparum is the most 
dominant and causes about 98% of all malaria infections 
in Malawi. Malaria transmission occurs throughout the 
year with highest transmission rates occurring between 
October and April (rainy season), mainly in low-lying 
and high temperature areas.
Study design, data collection and ethics statement
The data for this analysis were taken from the iLiNS-
DOSE and iLiNS-DYAD-M studies—two large commu-
nity-based randomized controlled trials conducted in 
rural Malawi.
In the iLiNS-DOSE study, 6-months old children were 
randomly allocated to one of five intervention groups 
provided with different doses or formulations of LNS 
or to a control group that did not receive LNS during 
the 12-month study period, between November 2009 
and May 2012. In the iLiNS-DYAD-M study, pregnant 
women < 20 weeks’ gestation were randomly allocated to 
one of three groups to receive iron and folic acid (IFA), 
multiple micronutrients (MMN) or a small-quantity 
(20  g) of LNS daily. After delivery, women in the IFA 
group received placebo tablets, while MMN and LNS 
supplementation was continued up to 6 months postpar-
tum. Children of mothers in the LNS group also received 
LNS 10 g twice daily from 6 to 18 months. This study was 
conducted from February 2011 to April 2015. Details of 
design, randomization and enrolment for the two studies 
can be found in the main outcome papers [15, 16].
In both studies, research assistants visited the children’s 
homes every week from age 6 to 18 months to interview 
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the guardians about the child’s health in the previous 
7 days using a structured questionnaire. The information 
was complemented by a picture calendar filled out by the 
guardians daily to aid memory of their children’s mor-
bidity status. These were done to minimise problems of 
recall associated with community morbidity assessments 
[22, 23]. The use of maternal interviews to collect data 
on child morbidity has been validated in previous stud-
ies [24, 25]. The research assistants referred all cases of 
fever to the nearby health facility for a malaria rapid diag-
nostic test (RDT) and treatment with artemether/lume-
fantrine, the nationally recommended anti-malarial drug. 
The children were followed throughout the year, covering 
periods of both high and low malaria transmission.
Facility health workers were trained to collect data 
on clinical diagnosis, RDT, and/or malaria microscopy 
results whenever the child was treated at the health 
facility. In addition, all children had malaria microscopy 
tests done during the scheduled study clinic visits at age 
6  months and 18  months. Blood smears were obtained 
from all children at the time of the blood sampling for 
biochemical assessments, stained with 2% Giemsa for 
30 min. All thick slides were reviewed by two microsco-
pists using a high-power microscope to determine the 
presence of malaria parasites. Discrepant readings were 
resolved by a third reviewer. Malaria RDT was also done 
at 6  months scheduled clinic visit using rapid test kit 
(Clearview Malarial Combo, Alere, South Africa).
Anthropometric assessments were done at 6 months and 
18 months. Study anthropometrists measured the infant’s 
length with a high-quality length board (Harpenden Infan-
tometer; Holtain Limited) and recorded it to the nearest 
1  mm. They weighed unclothed infants with electronic 
infant weighing scale (SECA 735; Seca GmbH & Co), 
recording to the nearest 10 g. The anthropometrists were 
trained and their measurement reliability was verified 
at the start of the study and at 6-months intervals there-
after with methods adapted from the procedures used in 
the WHO Multicentre Growth Reference Study [26]. The 
anthropometrists calibrated all equipment with standard 
weights and length rods daily.
Study nurses collected 5–7 mL of blood by venepunc-
ture using a 23-gauge needle into 7.5 mL evacuated, trace 
element-free polyethylene tubes containing lithium hep-
arin (Sarstedt Monovette, NH4‐heparin, Sarstedt Inc., 
Newton, NC, USA). The blood tube was immediately 
inverted 10 times to mix the heparin anticoagulant with 
the blood to prevent clotting. A small aliquot of the whole 
blood was pipetted out and used to analyse haemoglobin 
(Hb) on the Hemocue 201+ system (Hemocue, Brea, CA,
USA). The tube containing the remaining whole blood 
was then placed in an insulated cooler with ice packs and 
processed within 2  h of collection. Trained laboratory 
staff then aliquoted whole blood into microcuvettes and 
measured zinc protoporphyrin (ZPP) concentration from 
unwashed venous blood sample using a haematofluorom-
eter (206D, AVIV Biomedical Inc., Lakewood, NJ, USA).
At enrolment, research assistants interviewed the 
mothers to obtain household level information includ-
ing assets, number of children, maternal education (years 
spent in school) and maternal age. Household food 
security was assessed using Household Food Insecurity 
Access Scale (HFIAS) [27]. Use of insecticide treated 
bed nets (ITNs) was assessed by asking the guardians the 
number of days that the child slept under a bed net dur-
ing the week preceding the interview at 6  months. Site 
was defined based on the clinics where the two studies 
were conducted (i.e. Namwera, Mangochi, Malindi, and 
Lungwena).
Definition of the predictors and the outcomes
Outcome variables
The primary outcome for this analysis was the incidence 
of ‘presumed’ malaria, derived from the weekly morbidity 
data. ‘Presumed’ malaria diagnosis was defined as history 
of fever either reported by the guardians or tympanic 
temperature ≥ 38 °C measured by the research assistants
during the home visit. An episode of ‘presumed’ malaria 
was defined as the period starting from the day the child 
had malaria symptoms, preceded by at least 2 days of no 
symptoms or no data. The episode ended on the last day 
the child had malaria symptoms, if followed by at least 
2 symptom-free days. Fever episodes accompanied by 
respiratory signs or diarrhoea were excluded from the 
malaria diagnosis.
Secondary outcomes included (1) incidence of clinical 
malaria, taken from the malaria diagnosis made by the 
health worker in the absence of a diagnostic test when-
ever the child visited a health facility, (2) incidence of 
confirmed malaria, taken from the malaria diagnosis 
made by the health worker confirmed by a positive RDT, 
and (3) prevalence of malaria parasitaemia derived from 
the malaria microscopy results at age 18 months. Malaria 
incidence was calculated as total episodes of malaria/
total child years at risk; malaria parasitaemia prevalence 
was calculated as the proportion with a positive malaria 
parasite slide.
Predictor variables
Length for age z-scores (LAZ), weight-for-age z-scores 
(WAZ), and weight for length z-scores (WLZ) were 
calculated from the anthropometry data using WHO 
growth standards [26]. Iron deficiency at age 6  months 
was defined as whole blood ZPP > 70  µmol/mol haem 
[28]. HFIAS z-scores were generated by summing the 
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value of responses to nine questions regarding food inse-
curity: the higher the score, the higher degree of food 
insecurity in the last 4 weeks [27]. Household asset scores 
were defined as the principal components score based on 
baseline ownership of a set of assets and household qual-
ity: the higher the score, the better the living conditions. 
Number of children aged < 5  years was defined as num-
ber of children below the age of five who were part of the 
participant’s household at 6 months.
Statistical analysis
All children who had malaria data at any point from age 
6 to 18  months were included in the analysis. Negative 
binomial regression was used to assess the association 
of LAZ, WAZ, and WLZ (independent variables) with 
the incidence of malaria (dependent variable), and Pois-
son regression (with a robust variance estimator) [29] 
to assess the association of LAZ, WAZ, and WLZ with 
prevalence of malaria parasitaemia.
To study the independent effect of various predictors, 
multivariate regression models were constructed that 
included potential predictors collected at 6 months. The 
following were potential predictors: household asset 
scores, maternal age (centred around the mean), and edu-
cation, number of children aged < 5  years, HFIA score, 
whether the child received the study intervention (LNS) 
or not, adjusted for the additional control group [MMN] 
in iLiNS-DYAD, sex of the child, Hb concentration, iron 
status, month of birth, daily use of ITNs, distance to 
health facility and study site. Collinearity among the pre-
dictors was tested using the collin stata command. If the 
predictors were highly collinear (> 0.5), the one that was 
less strongly associated with the outcomes was dropped.
The results are reported as incidence rate ratios [IRR] 
or prevalence ratio [PR] and their 95% confidence inter-
vals (95% CI) at p = 0.05. Robust standard errors were 
computed to adjust for correlation of recurrent malaria 
episodes in a single child.
Other potential predictors were considered including 
immunization status, markers of inflammation (C-reactive 
protein and alpha1-acid glycoprotein concentrations) at 
6 months, maternal and child malaria immunity, and mater-
nal HIV status. However, these variables were available only 
from a subsample of the two studies, hence were eventu-
ally dropped from the final models to maximize the sample 
size. Furthermore, these variables showed little effect on the 
model during sensitivity analysis. Stata version 14 (Stata-
Corp, Texas, USA) was used for the main analyses.
Results
Study population
Of the 2723 children enrolled in the two study cohorts, 
2561 (94%) had data for the primary outcome (1928 
children from the iLiNS DOSE study and 633 children 
from the iLiNS DYAD-M study). These were included in 
the final analysis (Fig. 1). At age 6 months, the mean (SD) 
length-for-age z-scores (LAZ), weight-for-age z-scores 
(WAZ), and weight-for-length z-scores (WLZ) were 
− 1.4 (1.1), − 0.7 (1.2), and 0.3 (1.1) respectively. The pro-
portions of children who were stunted, underweight and 
wasted were 28.3%, 12.9%, and 2.0%, respectively. Further 
characteristics of these children at age 6 months are sum-
marized in Table 1.
Incidence and prevalence of malaria
The children contributed 2405.6 child years of follow 
up, i.e. the mean (SD) duration of follow up was 344 
(73) days/child. During the home visits, 27,340 mor-
bidity episodes were reported, 9.3% (2549/27,340) 
of which were episodes of ‘presumed’ malaria. The 
rest were due to: ARI, 53.8% (14,708/27,340); diar-
rhoea, 23% (6282/27,340) and minor conditions, 13.9% 
(3801/27,340).
Of the total morbidity episodes identified at the home 
visits, 44% (12,048/27,340) were reported and treated at a 
health facility, 32.5% (3917/12,048) of which were treated 
for malaria, 76.8% (3007/3917) of them confirmed by 
RDT.
From the home visits data, the mean (SD) incidence of 
all illnesses combined was 16.2 (13.1) episodes per child 
year. The mean (SD) incidence of ‘presumed’ malaria 
was 1.1 (1.6) episodes per child year. The mean (SD) 
incidence of acute respiratory infections was 7.8 (8.0) 
episodes per child year and the mean (SD) incidence 
of diarrhoea was 2.7 (2.7) episodes per child year. Con-
versely, the national data show that diarrhoea incidence 
is higher than ARI incidence in children under-five, 
probably because the age ranges are slightly different. 
The national data do not provide specific incidences for 
children under 18 months.
From the hospital visits data, the mean (SD) incidences 
of clinical malaria and confirmed malaria were, respec-
tively, 0.4 (0.8) and 1.3 (2.0) episodes per child year (i.e. 
the mean (SD) incidence of all malaria at hospital visits 
was 1.7 (2.4) episodes per child year).
The prevalence of malaria parasitaemia (by micros-
copy) increased from 4.8% at age 6  months to 9.6% 
at age 18  months. During the 12-month follow up 
period, 45.1% (1156/2561) of the children included 
in this analysis did not report any episode of malaria, 
28.4% (728/2561) reported one episode and 26.4% 
(677/2561) reported > 1 malaria episodes. The children 
who reported > 1 malaria episodes were responsible for 
71.4% (1821/2549) of all malaria episodes reported in 
the two studies. These findings were similar across the 
different definitions of malaria.
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Association of LAZ at 6 months with malaria from 6 
to 18 months
In bivariate analysis, a higher LAZ at 6  months was 
associated with a lower incidence of clinical malaria 
and lower incidence of confirmed malaria from 6 to 
18  months (Table  2, unadjusted), and lower preva-
lence of malaria parasitaemia at 18  months (Table  3, 
unadjusted), but not incidence of ‘presumed’ malaria 
(Table  2, unadjusted). When adjusted for other pre-
dictors, these associations were no longer evident 
(Tables 2, 3, adjusted, and 4).
Association of WLZ at 6 months with malaria from 6 
to 18 months
There was no association between WLZ at 6 months and 
the incidence of ‘presumed’ malaria, clinical malaria or 
confirmed malaria from 6 to 18 months, in either bivari-
ate or multivariate analyses (Table  2). In multivariate 
analysis, higher WLZ at 6  months was associated with 
lower prevalence of malaria parasitaemia at 18  months, 
adjusted for other predictors (i.e. 1 SD higher WLZ at 
6 months was associated with 20% decrease in prevalence 
of malaria parasitaemia at 18 months) (Tables 3, 4).
Association of WAZ at 6 months with malaria from 6 
to 18 months
In bivariate analysis, a higher WAZ at 6 months was asso-
ciated with lower incidence of confirmed malaria from 6 
to 18 months (Table 2, unadjusted), and lower prevalence 
of malaria parasitaemia at 18  months (Tables  3, unad-
justed, 4), but not incidence of ‘presumed’ malaria nor 
incidence of clinical malaria (Table 2, unadjusted). When 
adjusted for other predictors, these associations were no 
longer evident (Tables 2, 3, adjusted and 4).
Independent predictors of malaria
Independent predictors that were significantly associ-
ated with malaria outcomes are presented in Tables  3, 
4. Incidence of ‘presumed’ malaria from 6 to 18 months
was independently associated with maternal age and
asset score at 6  months (i.e. each year higher in mater-
nal age was associated with 1% increase in incidence
of ‘presumed’ malaria; and 1 SD higher asset score was
associated with 14% decrease in incidence of ‘presumed’
malaria).
Incidence of clinical malaria from 6 to 18 months was 
independently associated with Hb concentration and 
HFIAS at 6 months (i.e. each g/L higher Hb at 6 months 
Fig. 1 Flow chart of the children enrolled and included in the final analysis. The figure shows the number of children enrolled, children lost to 
follow up, and children who were eventually included in the analysis from the iLiNS DOSE and iLiNS DYAD-M cohorts
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was associated with 1% decrease in incidence of clinical 
malaria; and 1-unit higher HFIAS was associated with 
2% increase in incidence of clinical malaria). Higher 
HFIAS represents higher degree of food insecurity. 
There was also a significant variation in the incidence 
of clinical malaria between the health facilities (study 
sites), with Namwera site reporting higher incidence of 
clinical malaria compared to Mangochi, while the other 
two sites (Malindi and Lungwena) had lower incidence 
of clinical malaria compared to Mangochi.
Incidence of confirmed malaria from 6 to 18 months 
was independently associated with iron deficiency, 
maternal education and asset score at 6  months (i.e. 
iron deficiency at 6  months was associated with 20% 
higher incidence of confirmed malaria; each year higher 
in maternal schooling was associated with 3% decrease 
in incidence of confirmed malaria; 1 SD higher asset 
score was associated with 27% decrease in incidence of 
confirmed malaria). There was also a significant varia-
tion in the incidence of confirmed malaria between the 
study sites with Namwera site reporting higher inci-
dence of confirmed malaria compared to Mangochi, 
while the other two sites (Malindi and Lungwena) 
reported lower incidence of confirmed malaria com-
pared to Mangochi.
Independent predictors of malaria parasitaemia prev-
alence were WLZ, maternal age, maternal education, 
Hb concentration, and iron deficiency (i.e. 1 SD higher 
WLZ was associated with 20% decrease in prevalence of 
malaria parasitaemia (see Tables 3, 4); each year higher in 
maternal age was associated with 3% decrease in preva-
lence of malaria parasitaemia; each additional year in 
maternal schooling was associated with 10% decrease in 
prevalence of malaria parasitaemia; each g/L higher Hb 
at 6  months was associated with 2% decrease in preva-
lence of malaria parasitaemia; and iron deficiency at 
Table 1 Participant characteristics at age 6 months
ITN, insecticide-treated bed nets; LNS, lipid-based nutrient supplement; RDT, malaria antigen rapid diagnostic test; ZPP, zinc protoporphyrin
a Measured from unwashed venous blood
b A week prior to the day of assessment
Mean (SD) or n (%) N
Child factors
Mean (SD) weight-for-length z-score 0.3 (1.1) 2561
Mean (SD) weight-for-age z-score − 0.7 (1.2) 2561
Mean (SD) length-for-age z-score − 1.4 (1.1) 2561
Mean (SD) haemoglobin, g/L 104 (16) 2523
Proportion of boys 1265 (49.4%) 2561
Proportion wasted 50 (2.0%) 2561
Proportion underweight 330 (12.9%) 2561
Proportion stunted 725 (28.3%) 2561
Proportion with haemoglobin < 105 g/L 1334 (51.5%) 2523
Proportion with ZPP > 70 µmol/mole  haema 1567 (66.1%) 2371
Proportion with malaria positive by RDT 349 (14.6%) 2389
Maternal factors
Mean (SD) maternal age (years) 25.8 (6.2) 2265
Mean (SD) maternal education, completed years 4.4 (3.6) 2425
Socio-economic and household factors
Mean (SD) Household Food Insecurity Access Score 6.1 (5.6) 2128
Mean (SD) asset score − 0.02 (0.99) 2179
Mean (SD) number of children aged < 5 years in the household 1.6 (0.7) 2149
Proportion who slept under ITN  dailyb 2065 (81.1%) 2546
Environmental factors
Proportion who received LNS intervention 1804 (70.6%) 2556
Study site
Mangochi 1667 (65.2%) 2561
Namwera 445 (17.4%) 2561
Malindi 120 (4.7%) 2561
Lungwena 324 (12.7%) 2561
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6 months was associated with 111% higher prevalence of 
malaria parasitaemia).
Discussion
The study hypothesis was that lower length for age 
z-scores (LAZ) and lower weight for length z-scores
(WLZ) at 6  months will be associated with a higher
incidence of malaria from 6 to 18  months and higher
prevalence of malaria parasitaemia at 18  months. In a
sample of 2561 Malawian children, LAZ at 6  months
was not associated with incidence of malaria from 6 to
18  months, nor prevalence of malaria parasitaemia at
18 months. Higher WLZ at 6 months was associated with
lower prevalence of malaria parasitaemia at 18  months
(20% decrease in prevalence of malaria parasitaemia at
18 months for every 1 SD higher WLZ at 6 months), but
not with incidence of malaria from 6 to 18 months.
The longitudinal study design helped to determine the 
temporality of the associations because (1) malaria out-
comes were obtained from 6 to 18  months after identi-
fying the predictors at 6 months, and (2) malaria is less 
Table 3 Association of  length-for-age, weight-for-length, 
and  weight-for-age z-scores at  age 6  months with 
prevalence of malaria parasitaemia at age 18 months
CI: confidence interval; LAZ: length-for-age z-score; PR: prevalence ratio; WAZ: 
weight-for-age z-score; WLZ: weight-for-length z-score
a Positive result from malaria microscopy readings
b Adjusted for the following factors at age 6 months: sex of the child, 
haemoglobin concentration, iron status, month of birth, daily use of insecticide-
treated bed nets, distance to health facility, study site, asset scores, maternal 
age, maternal education, children < 5 years, HFIA score, and whether the child 
received the study intervention (LNS) or not
c Prevalence ratio, obtained using a modified Poisson regression (with a robust 
variance estimator) [29]. The PR represents the rate of change in prevalence of 
malaria parasitaemia for each 1-SD higher LAZ, WAZ, or WLZ
Prevalence of malaria parasitaemia at age 18 months 
(N = 1662)a
Unadjusted Adjustedb
PRc (95% CI) p-value PRc (95% CI) p-value
Predictor at age 6 months
LAZ 0.82 (0.72 to 0.93) 0.003 1.11 (0.93 to 1.33) 0.259
WLZ 1.01 (0.88 to 1.16) 0.877 0.80 (0.67 to 0.94) 0.007
WAZ 0.85 (0.75 to 0.96) 0.007 0.88 (0.75 to 1.03) 0.115
Table 4 Independent predictors of incidence and prevalence of malaria in multivariate analysis
Other factors included in the models but not significant were: sex of the child, birth month, number of children in household, and daily use of insecticide-treated bed 
nets
CI: confidence interval; IRR: incidence rate ratio; LNS: lipid-based nutrient supplements; PR: prevalence ratio; ZPP: zinc protoporphyrin
a  Incidence rate ratio, obtained using negative binomial regression. The IRR represents the rate of change in incidence of malaria (for each 1-unit higher in the 
continuous predictors or for each group compared to the reference group in the categorical predictors), adjusted for other variables
b  Prevalence ratio, obtained using a modified Poisson regression (with a robust variance estimator) [29]. The PR represents the rate of change in prevalence of malaria 
parasitaemia (for each 1-unit higher in the continuous predictors or for each group compared to the reference group in the categorical predictors), adjusted for other 
variables
c  ZPP > 70 µmol/mol heme [28]
Incidence of ‘presumed’ 
malaria (N = 2561)
Incidence of clinical 
malaria (N = 2497)
Incidence of confirmed 
malaria (N = 2497)
Prevalence of malaria 
parasitaemia at age 
18 months (N = 1662)
IRRa (95% CI) p-value IRRa (95% CI) p-value IRRa (95% CI) p-value PRb (95% CI) p-value
Child factors at age 6 months
Haemoglobin (g/L) 1.00 (0.99 to 1.01) 0.529 0.99 (0.98 to 1.00) 0.016 1.00 (0.99 to 1.01) 0.845 0.98 (0.97 to 0.99) 0.001
Iron  deficiencyc 1.04 (0.91 to 1.18) 0.587 1.03 (0.83 to 1.28) 0.773 1.20 (1.04 to 1.39) 0.012 2.11 (1.24 to 3.57) 0.006
Maternal factors at enrollment
Maternal age 1.01 (1.00 to 1.02) 0.011 0.99 (0.97 to 1.01) 0.149 1.00 (0.98 to 1.01) 0.200 0.97 (0.94 to 0.99) 0.033
Maternal education 0.99 (0.97 to 1.01) 0.427 1.00 (0.98 to 1.03) 0.783 0.97 (0.95 to 0.99) 0.024 0.90 (0.85 to 0.96) 0.001
Household factors at enrollment
Household Food Insecurity 
Access Score
1.00 (0.99 to 1.01) 0.809 1.02 (1.01 to 1.04) 0.022 1.01 (0.99 to 1.02) 0.065 1.02 (0.99 to 1.05) 0.184
Asset scores 0.86 (0.80 to 0.93) < 0.001 0.94 (0.83 to 1.07) 0.343 0.73 (0.64 to 0.83) < 0.001 0.92 (0.63 to 1.34) 0.666
Environmental factors
LNS intervention (vs control) 1.00 (0.88 to 1.14) 0.983 1.11 (0.89 to 1.37) 0.343 1.02 (0.86 to 1.22) 0.783 1.07 (0.70 to 1.62) 0.765
Study site
Mangochi Reference Reference Reference Reference
Namwera 0.94 (0.81 to 1.09) 0.457 1.49 (1.20 to 1.85) < 0.001 1.73 (1.50 to 1.99) < 0.001 1.49 (0.99 to 2.24) 0.054
Malindi 1.12 (0.88 to 1.42) 0.337 0.45 (0.27 to 0.73) 0.001 0.58 (0.43 to 0.78) < 0.001 0.74 (0.29 to 1.88) 0.531
Lungwena 0.91 (0.75 to 1.09) 0.303 0.24 (0.14 to 0.41) < 0.001 0.33 (0.25 to 0.44) < 0.001 0.65 (0.36 to 1.19) 0.163
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common in children < 6  months due to the protective 
effect of fetal haemoglobin and maternal antibodies 
[30–32]. Another strength of the study was the enhance-
ment of morbidity recall using a daily pictorial calendar 
which minimized recall bias associated with home mor-
bidity assessments [22, 23]. The study had a long follow 
up which allowed assessment of the associations in all 
seasons, and by pooling data from two large cohorts we 
ended up with a large sample size with adequate power to 
detect associations.
The main weakness of the study is the change in the 
exposure (anthropometric status) during the follow up. 
There was significant decrease in mean LAZ, WAZ, and 
WLZ from 6 months to 18 months. Compared to base-
line, more children had developed stunting, underweight, 
and wasting by 18  months (41.5% vs 28.3%, 16.5% vs 
12.9%, and 5% vs 2% respectively), indicating that some 
children became nutritionally worse off during follow up 
which may have led to misclassification bias.
There is possibility of residual confounding due to 
unmeasured factors associated with malaria including 
HIV infection [33], polyparasitism [34], vitamin A and 
zinc deficiency [35–38], and genetic variations including 
haemoglobinopathies [39–41].
Presumptive diagnosis of malaria may also have led to 
overestimating the outcome whereas the use of RDT-
confirmed malaria may have led to under-estimating the 
outcome because (1) 23% of the children were treated 
for malaria at the hospital without RDT confirmation, 
and (2) children who had malaria episodes but received 
home treatment or no treatment and did not present to 
the hospitals were missed (only 44% of the morbidity epi-
sodes were treated at the hospital). However, the consist-
ency of the results across the different malaria definitions 
suggests that this weakness did not bias the results, and 
considering the strengths of this study, the conclusions 
are reasonably valid.
The finding of no association between stuntedness 
at 6  months and malaria in the subsequent 12-month 
period is similar to results of previous studies [42–45], 
which suggests that stunting may be of little significance 
in malaria epidemiology. These results are however dif-
ferent from those of other studies that reported an 
increased risk of malaria associated with stunting. In the 
Gambia, a prospective study of children aged < 5  years 
reported an increased risk of malaria associated with 
stunting (crude RR = 1.35; 95% CI 1.08–1.69) [9]. The 
follow up was very short (during the malaria season 
that lasted only 20  weeks), and although the outcomes 
were adjusted for age, sex, and ethnicity, crude RR were 
reported. The authors also did not adjust for socio-eco-
nomic and household factors therefore could not rule 
out the influence of these confounders in their results. In 
Kenya, stunting in children aged 0–36 months was asso-
ciated with an increased odds of malaria parasitaemia 
(odds ratio = 1.98, p < 0.0001) [10]. The cross-sectional 
design of this study suggests the observed association 
may have been due to reverse causation, i.e. the cumu-
lative deleterious effects of malaria on linear growth. In 
Uganda, mild stunting (IRR = 1.24, 95% CI 1.06–1.46) 
and moderate-severe stunting (IRR = 1.24, 95% CI 1.03–
1.48) in children aged < 2.5  years were associated with 
increased incidence of malaria parasitaemia [11]. How-
ever, although this was a cohort study, it was not clear 
whether exposure assessment preceded the outcomes, 
therefore, the temporal relationship between stunting 
and risk of malaria was difficult to ascertain.
However, a study in Papua New Guinea reported 
that lower LAZ was associated with lower incidence of 
malaria in the subsequent one-year period, attributed 
to increased interferon γ (IFN-γ) response to specific 
malarial antigens observed in stunted children, although 
the mechanisms were not fully explained [46]. Malaria 
varies with age (incidence of malaria decreases whereas 
prevalence of malaria parasitaemia increases with age) 
[13, 47, 48], therefore, the wide age range of the study 
participants (from 10 months to 10 years) makes for diffi-
cult comparisons between the studies. In the Papua New 
Guinea study, the authors noted that interferon-γ release 
increased with age, the prevalence rates of splenomegaly 
and parasitaemia increased with age, whereas the inci-
dence of malaria decreased with age, further muddling 
the interpretation of the findings.
In this population, supplementation with LNS did 
not alter malaria antibody acquisition [49], which was 
attributed to the finding that the nutritional supple-
ments also did not promote infant growth [16]. Further 
analysis showed no difference in malaria antibody acqui-
sition between the stunted and non-stunted children at 
6 months (data not shown), supporting the null findings.
In this study, higher WLZ at 6  months was associ-
ated with lower prevalence of malaria parasitaemia at 
18 months, when adjusted for other predictors. Wasting 
is associated with low levels of leptin through depletion 
of fat mass [50]. Low levels of leptin can lead to reduced 
immune response [51], resulting in increased risk of 
malaria associated with wasting. So far, the evidence 
of association (increased or decreased risk) of malaria 
with WLZ has mainly come from cross-sectional stud-
ies [10, 52, 53]. A recent systematic review determined 
that the relationship between wasting and risk of malaria 
is hitherto inconclusive with most longitudinal stud-
ies reporting no association [54]. This association was 
not conclusive and may be due to chance (e.g., because 
of multiple testing [55]), considering that WLZ was 
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significantly associated with prevalence of malaria para-
sitaemia only and not with the other malaria outcomes.
In this study, only 30% of the children reported frequent 
malaria episodes. Knowledge of this over-dispersion in 
malaria infections is important because interventions 
targeted at this core group could be the most effective [7]. 
However, providing routine screening to identify such 
children is difficult. Platforms such as growth monitoring 
and promotion clinics (GMP) provide an entry point to 
preventive and curative health care and have been associ-
ated with significant reductions in malnutrition and mor-
tality [56].
Such platforms can be useful for malaria screening 
especially in malaria hypoendemic or mesoendemic set-
tings where targeting malaria interventions to under-
nourished children has potential to reduce malaria 
morbidity and mortality [57]. In this setting, socio-eco-
nomic factors such as household asset scores, maternal 
education, and food insecurity were significantly associ-
ated with malaria. There were also variations in hospital-
diagnosed malaria by study site, with the Namwera site 
reporting higher incidences of clinical and RDT-con-
firmed malaria compared to the other three study sites. 
These factors may be more important than anthropomet-
ric status in malaria epidemiology but were not explored 
further in this analysis.
Conclusions
In conclusion, in children aged 6 to 18 months living in 
this malaria-endemic setting, LAZ, WAZ, and WLZ do 
not predict subsequent malaria incidence when adjusted 
for other predictors. However, WLZ may be associated 
with prevalence of malaria parasitaemia. Socio-economic 
factors and micro-geographic variations may explain 
most of the over-dispersion in malaria infections in this 
setting, but these require further study.
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